Interpace Biosciences, Inc. (IDXG)
1.523
-0.09
(-5.42%)
USD |
OTCM |
Aug 21, 16:00
Interpace Biosciences Total Liabilities (Quarterly) : 11.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.30M |
| March 31, 2026 | 10.33M |
| December 31, 2025 | 11.48M |
| September 30, 2025 | 12.33M |
| June 30, 2025 | 13.55M |
| March 31, 2025 | 15.08M |
| December 31, 2024 | 17.01M |
| September 30, 2024 | 25.18M |
| June 30, 2024 | 25.46M |
| March 31, 2024 | 26.75M |
| December 31, 2023 | 22.12M |
| September 30, 2023 | 30.39M |
| June 30, 2023 | 31.61M |
| March 31, 2023 | 31.88M |
| December 31, 2022 | 32.52M |
| September 30, 2022 | 30.35M |
| June 30, 2022 | 36.90M |
| March 31, 2022 | 36.16M |
| December 31, 2021 | 34.31M |
| September 30, 2021 | 32.42M |
| June 30, 2021 | 32.44M |
| March 31, 2021 | 30.22M |
| December 31, 2020 | 28.23M |
| September 30, 2020 | 25.96M |
| June 30, 2020 | 30.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.14M |
| December 31, 2019 | 29.85M |
| September 30, 2019 | 37.92M |
| June 30, 2019 | 19.50M |
| March 31, 2019 | 18.61M |
| December 31, 2018 | 15.50M |
| September 30, 2018 | 13.77M |
| June 30, 2018 | 12.80M |
| March 31, 2018 | 13.33M |
| December 31, 2017 | 13.73M |
| September 30, 2017 | 14.01M |
| June 30, 2017 | 17.40M |
| March 31, 2017 | 22.41M |
| December 31, 2016 | 35.25M |
| September 30, 2016 | 47.44M |
| June 30, 2016 | 47.52M |
| March 31, 2016 | 48.47M |
| December 31, 2015 | |
| September 30, 2015 | 93.43M |
| June 30, 2015 | 97.28M |
| March 31, 2015 | 95.99M |
| December 31, 2014 | 95.78M |
| September 30, 2014 | 36.80M |
| June 30, 2014 | 30.11M |
| March 31, 2014 | 34.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.1038M |
| Xcelerate, Inc. | 2.332M |
| Vivos Therapeutics, Inc. | 28.13M |
| Hinge Health, Inc. | 483.07M |
| PD-Rx Pharmaceuticals, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.55M |
| Shareholders Equity (Quarterly) | 23.24M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 2.215 |
| Net Debt Paydown Yield | 1.45% |